Search/
Company exports
CSV downloadsPro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
Semicap·6510.TWO
Chunghwa Precision Test Tech. Co., Ltd.
TWO · TW
Probe cards and test-interface products supplier.
AI relevance
Test-interface exposure for advanced SoCs and AI semiconductor validation.
Price
$3610.00
Change
+70.00 (+1.98%)
Market cap
$118.4B
52w range
$801–$4475
Exchange
TWO
Country
TW
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Price chart
6510.TWO market performance
Daily close for Chunghwa Precision Test Tech. Co., Ltd.
- Latest close
- $3,610
- Range move
- +$2,749 (+319.3%)
- Range high
- $4,200
- Range low
- $803.0
- Latest volume
- 392.6K
- Source
- FMP EOD
Downloads
CSVExports
Download statements, ratios, chart data, and transcript indexes.
Income statement
7 annual rowsRevenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Balance sheet
7 annual rowsCash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Cash flow
7 annual rowsOperating cash flow, capital expenditures, and free cash flow.
Key metrics
7 annual rowsEnterprise value, valuation multiples, returns, yields, and cash conversion.
Ratios
7 annual rowsMargins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Chart data
1219 rowsFive years of daily close and volume data powering the company chart.
Transcript list
0 rowsAvailable earnings-call transcript dates by fiscal year and quarter.
Download
Street
Analyst expectations
Annual estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $7.46B | $6.09B - $7.99B | $65.22 | $58.22 - $69.13 | $2.12B | $1.28B | $2.14B | $980.2M | 6 rev / 6 EPS |
| 2027-12-31 | $11.49B | $7.21B - $12.81B | $112.45 | $60.85 - $130.47 | $3.26B | $1.97B | $3.69B | $1.51B | 7 rev / 7 EPS |
| 2028-12-31 | $14.64B | $10.27B - $16.08B | $148.62 | $90.91 - $167.61 | $4.15B | $2.51B | $4.88B | $1.92B | 4 rev / 5 EPS |
Quarterly estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.61B | $1.54B - $1.74B | $13.08 | $11.99 - $14.70 | $455.9M | $275.7M | $425.0M | $211.2M | 6 rev / 6 EPS |
| 2026-09-30 | $2.12B | $1.49B - $2.39B | $19.58 | $17.75 - $22.21 | $602.8M | $364.6M | $636.2M | $279.3M | 6 rev / 5 EPS |
| 2026-12-31 | $2.37B | $1.92B - $2.62B | $22.55 | $17.02 - $25.68 | $672.2M | $406.5M | $732.7M | $311.4M | 5 rev / 1 EPS |
| 2027-03-31 | $1.67B | $1.36B - $1.85B | $20.88 | $15.76 - $23.77 | $474.7M | $287.1M | $678.4M | $219.9M | 3 rev / 1 EPS |
| 2027-06-30 | $1.80B | $1.46B - $2.00B | $23.31 | $17.60 - $26.54 | $511.6M | $309.4M | $757.4M | $237.0M | 3 rev / 1 EPS |
| 2027-09-30 | $1.81B | $1.47B - $2.01B | $25.50 | $19.25 - $29.04 | $514.5M | $311.1M | $828.7M | $238.3M | 3 rev / 1 EPS |
| 2027-12-31 | $1.52B | $1.24B - $1.69B | $36.87 | $27.83 - $41.98 | $432.7M | $261.7M | $1.20B | $200.4M | 3 rev / 1 EPS |
Price target history
No price target summary on file.
Latest grade actions
No grade actions on file.
Historical rating snapshots
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 2 | 4 | 1 | 0 | 0 |
| 2026-05-01 | 2 | 4 | 1 | 0 | 0 |
| 2026-04-01 | 2 | 4 | 0 | 0 | 0 |
| 2026-03-01 | 2 | 4 | 1 | 0 | 0 |
| 2026-02-01 | 2 | 4 | 1 | 0 | 0 |
| 2026-01-01 | 2 | 2 | 2 | 0 | 0 |
| 2025-12-01 | 1 | 2 | 3 | 0 | 0 |
| 2025-11-01 | 1 | 2 | 3 | 0 | 0 |
FinancialsFY 2025
Financials
Income statement annual
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $4.81B | $2.67B | 55.5% | $867.8M | $1.19B | $1.61B | $997.2M | $30.41 |
| FY 2024 | $3.60B | $1.93B | 53.5% | $872.9M | $488.9M | $1.01B | $509.7M | $15.55 |
| FY 2023 | $2.88B | $1.39B | 48.2% | $965.1M | -$52.7M | $437.9M | $32.6M | $0.99 |
| FY 2022 | $4.39B | $2.29B | 52.1% | $954.4M | $911.8M | $1.35B | $770.6M | $23.50 |
| FY 2021 | $4.24B | $2.29B | 54.0% | $780.9M | $1.08B | $1.47B | $891.8M | $27.20 |
| FY 2020 | $4.21B | $2.28B | 54.1% | $671.4M | $1.17B | $1.53B | $933.7M | $28.48 |
| FY 2019 | $3.39B | $1.80B | 53.1% | $570.4M | $870.0M | $1.10B | $625.2M | $19.07 |
Cash flow annual
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $1.57B | $153.3M | $1.41B |
| FY 2024 | $615.8M | $146.3M | $454.7M |
| FY 2023 | $325.2M | $283.1M | $28.1M |
| FY 2022 | $1.40B | $979.0M | $421.9M |
| FY 2021 | $1.09B | $512.2M | $577.5M |
| FY 2020 | $1.48B | $545.1M | $937.8M |
| FY 2019 | $507.1M | $1.39B | -$886.6M |
Balance sheet annual
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $4.40B | $688.0M | $787.1M | $3.88B | $9.95B | $25.4M | -$3.98B | $1.17B | $8.77B |
| FY 2024 | $3.25B | $1.05B | $570.6M | $4.12B | $9.16B | $29.4M | -$3.06B | $1.10B | $8.04B |
| FY 2023 | $2.80B | $600.2M | $326.4M | $4.41B | $8.27B | $39.7M | -$2.65B | $698.9M | $7.53B |
| FY 2022 | $3.15B | $776.3M | $439.8M | $4.53B | $9.04B | $40.3M | -$2.98B | $1.08B | $7.88B |
| FY 2021 | $3.10B | $1.07B | $452.6M | $3.98B | $8.72B | $47.0M | -$2.97B | $1.18B | $7.55B |
| FY 2020 | $2.92B | $800.8M | $363.2M | $3.92B | $8.13B | $26.7M | -$2.83B | $1.08B | $7.05B |
| FY 2019 | $0 | $908.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Annual ratios and key metrics
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 55.5% | 24.8% | 20.7% | 5.1x | 4.4x | 11.4% | 10.9% | 14.8x | 44.2x | 1.9% | 18.1% | 142d |
| FY 2024 | 53.5% | 13.6% | 14.1% | 4.6x | 4.0x | 6.3% | 5.3% | 7.2x | 25.7x | 1.6% | 24.2% | 148d |
| FY 2023 | 48.2% | -1.8% | 1.1% | 5.6x | 5.1x | 0.4% | 0.1% | 5.3x | 35.2x | 0.2% | 33.5% | 110d |
| FY 2022 | 52.1% | 20.8% | 17.6% | 4.2x | 3.8x | 9.8% | 9.6% | 2.8x | 9.1x | 2.8% | 21.7% | 90d |
| FY 2021 | 54.0% | 25.6% | 21.0% | 4.1x | 3.7x | 11.8% | 11.8% | 4.8x | 13.9x | 2.5% | 18.4% | 111d |
| FY 2020 | 54.1% | 27.8% | 22.2% | 3.8x | 3.5x | 13.2% | 13.2% | 5.3x | 14.5x | 3.7% | 16.0% | 109d |
| FY 2019 | 53.1% | 25.7% | 18.5% | 0.0x | 0.0x | 0.0% | 4540.9% | 10.0x | 30.7x | -2.6% | 16.8% | 33d |
Annual growth
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | +33.3% | +38.5% | -0.6% | +143.5% | +95.6% | +95.6% | +211.0% | +0.6% | +35.2% | +37.9% | +8.7% | -13.6% |
| FY 2024 | +25.0% | +38.5% | -9.5% | +1027.2% | +1463.5% | +1470.7% | +1520.8% | +45.8% | +16.5% | +74.8% | +10.7% | -26.1% |
| FY 2023 | -34.3% | -39.2% | +1.1% | -105.8% | -95.8% | -95.8% | -93.4% | +69.6% | -11.3% | -25.8% | -8.5% | -1.6% |
| FY 2022 | +3.5% | -0.2% | +22.2% | -15.9% | -13.6% | -13.6% | -26.9% | -91.1% | +1.8% | -2.8% | +3.6% | -14.1% |
| FY 2021 | +0.8% | +0.6% | +16.3% | -7.3% | -4.5% | -4.5% | -38.4% | +6.0% | +6.1% | +24.6% | +7.2% | +76.0% |
| FY 2020 | +24.3% | +26.6% | +17.7% | +34.5% | +49.4% | +49.3% | +205.8% | +60.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| FY 2019 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Segments
Revenue Mix
Revenue segmentation data unavailable.
Transcripts
Transcripts
No transcripts on file.
Events
Events
Next earnings
2026-08-04EPS est $13.08